Skin Disorders News

In a panel-led project, 23 experts created a comprehensive guide for the long-term management of inflammatory skin diseases in pediatric patients treated with methotrexate.

Pediatric and adult chronic spontaneous urticaria exhibit distinct features, with adolescent presentations resembling those of adults more than those of younger children, according to a study published in Pediatric Allergy and Immunology.

The European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion of Adtralza for injection in a new single-dose 2 ml pre-filled pen, according to a press release.

The UCT7 reduces the Urticaria Control Test’s 4-week recall period to 7 days to assess disease control at short intervals in clinical studies and practice, according to a study published in The Journal of Allergy and Clinical Immunology.

Molecular changes in barrier function and inflammatory markers characterized the pathophysiology of atopic dermatitis at age 1 month, according to a study published in the Journal of the European Academy of Dermatology and Venereology.

As hundreds of wildfires in Canada drive haze and smoke across the East Coast, patients and providers alike may worry about the effect on their health, including asthma and other illnesses.

Healio compiled the most-read news in allergy, asthma and immunology posted in May.

Patients with moderate to severe atopic dermatitis that switched from dupilumab to upadacitinib experienced significant improvement in efficacy and itch as early as week 4 of treatment, according to a study.

Information about nutritional treatment for the atopic triad on YouTube tends to be dubious, with a recent study of 91 videos by Høj et al. classifying 65% of them as misleading and only 32% of them as useful.

The second of two phase 3 studies evaluating Vtama cream 1% in adults and children aged as young as 2 years with atopic dermatitis showed consistent safety and efficacy results, Dermavant Sciences announced in a press release.